ストックスクリーナーアプリを入手
3.52
2.50%
-0.08
アフターアワーズ：
3.51
-0.01
-0.28%
Altimmune Inc (ALT) 最新ニュース
Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Altimmune, Inc. (ALT) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
ALT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Altimmune, Inc. (ALT) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Shareholders Filed a Lawsuit Against Altimmune for Misleading Clinical Trial Disclosures - TradingView
Altimmune ($ALT) Misleading Pemvidutide Trial Results and Fibrosis Endpoint Failure Case - TradingView
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Applying chart zones and confluence areas to Altimmune Inc.Market Opportunity Tracker for Swing Traders - Newser
Order flow analysis tools used on Altimmune Inc.Free Earnings Play Trade Plan With Alerts - Newser
Investor Alert: Robbins LLP Informs Investors of the Altimmune, Inc. Class Action Lawsuit - GlobeNewswire
ALT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Altimmune, Inc. (ALT) Class ActionContact Levi & Korsinsky - Newsfile
Altimmune, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Altimmune Faces Legal Storm as Trial Results Disappoint - TipRanks
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Morningstar
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc.ALT - PR Newswire
Altimmune Inc. stock momentum explainedPrice Forecast Based on AI Analysis - Newser
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Altimmune, Inc. Securities and Sets a Lead Plaintiff Deadline of October 6, 2025 - Business Upturn
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
What makes Altimmune Inc. stock attractive to long term investorsFree Triple Return Setup with Risk Control - Newser
Altimmune reports Q2 2025 financial results on August 12. - AInvest
Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 | ALT Stock News - GuruFocus
Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 - The Manila Times
Why Altimmune Inc. stock attracts strong analyst attentionFree Weekly Return Pick Forecast Reports - Newser
Clinical-Stage Biotech Altimmune Sets Q2 2025 Earnings DateKey Details for Investors - Stock Titan
Analyzing recovery setups for Altimmune Inc. investorsFree Access to Smart Investment Tips - Newser
Levi & Korsinsky Investigates Altimmune, Inc. (ALT) Over Potential Securities Fraud Allegations - ACCESS Newswire
Market reaction to Altimmune Inc.’s recent newsTechnical Insight Guide for Safer Trades - Newser
Published on: 2025-08-04 04:35:56 - Newser
Should I hold or sell Altimmune Inc. stock in 2025Free Market Dynamics Reports - Jammu Links News
What are Altimmune Inc. company’s key revenue driversExtraordinary profit generation - Jammu Links News
Does Altimmune Inc. stock perform well during market downturnsRapid portfolio appreciation - Jammu Links News
What makes Altimmune Inc. stock price move sharplyCapitalize on high-growth stocks early - Jammu Links News
Is Altimmune Inc. a good long term investmentDynamic profit opportunities - Jammu Links News
Protect Your Investment: Contact Levi & Korsinsky About the Altimmune, Inc. (ALT) Investigation - ACCESS Newswire
What are the technical indicators suggesting about Altimmune Inc.Tremendous portfolio expansion - Jammu Links News
What catalysts could drive Altimmune Inc. stock higher in 2025Unlock powerful trading signals and alerts - Jammu Links News
How volatile is Altimmune Inc. stock compared to the marketCapitalize on momentum-driven stocks - jammulinksnews.com
How strong is Altimmune Inc. company’s balance sheetDiscover stocks with superior performance - Jammu Links News
Is Altimmune Inc. stock overvalued or undervaluedAchieve superior returns through strategic trading - Jammu Links News
Shareholders Alert: Investigation Into Altimmune, Inc. (ALT)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
How Altimmune Inc. stock performs during market volatilityReal Time Stock Movement and Alerts - Newser
What institutional investors are buying Altimmune Inc. stockFree Stock Data Feed Backed By Experts - Jammu Links News
Altimmune, Inc. (ALT) Stock Analysis: Exploring The 376.96% Potential Upside - DirectorsTalk Interviews
Is Altimmune Inc. reversing from oversold territorySafe Momentum Strategy With Trend Analysis - Newser
What is the risk reward ratio of investing in Altimmune Inc. stockExpert Picks Insights For Fast Growth - Jammu Links News
Altimmune Bets Big On Next-Gen Obesity And Liver Drugs - Finimize
Levi & Korsinsky Launches Fraud Investigation on Behalf of Altimmune, Inc. (ALT) Shareholders - ACCESS Newswire
Published on: 2025-07-31 05:27:57 - Newser
How to use a screener to detect Altimmune Inc. breakoutsTechnical Reversal Pattern Summary and Tracker - Newser
Altimmune Inc. stock daily chart insightsGrowth Based Investment Plan Guidance Highlighted - metal.it
How sentiment analysis helps forecast Altimmune Inc.Chart Pattern Recognition for Profit Timing - Newser
Regression analysis insights on Altimmune Inc. performanceWeekly Chart-Based Forecast for Traders - Newser
Is Altimmune Inc. stock reversal real or fakeEntry Opportunity Screener with Confirmation - Newser
Altimmune, Inc. Securities Lawsuit Investigation - Claim Depot
0.68%
0.34%
大文字化:
|
ボリューム (24 時間):